{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "Echinaforce\u00ae ist der standardisierte Extrakt von <i>Echinacea purpurea</i> (Bioforce, Schweiz). J\u00fcngste Studien zeigen eine Immunmodulation und breite antivirale Effekte gegen Atemwegsviren. H\u00e4-magglutinin und Neuraminidase werden blockiert. Im Gegensatz zu Oseltamivir bewirkt Echinaforce\u00ae keine Resistenz. Eine randomisierte, plazbokontrollierte Doppelblindstudie \u00fcber vier Monate best\u00e4tigt, dass Echinaforce\u00ae die Immunabwehr unterst\u00fctzt und direkt gegen h\u00e4ufige Atemwegsviren wirkt. Echinaforce\u00ae ist bei Atemwegsinfekten effizient und sicher in der Langzeit- und Kurzzeit-Pr\u00e4vention, sowie in der Akutbehandlung."
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23263637",
  "DateCompleted": {
    "Year": "2013",
    "Month": "09",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2012",
        "Month": "12",
        "Day": "20"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s10354-012-0166-0"
    ],
    "Journal": {
      "ISSN": "1563-258X",
      "JournalIssue": {
        "Volume": "163",
        "Issue": "3-4",
        "PubDate": {
          "Year": "2013",
          "Month": "Feb"
        }
      },
      "Title": "Wiener medizinische Wochenschrift (1946)",
      "ISOAbbreviation": "Wien Med Wochenschr"
    },
    "ArticleTitle": "Efficacy and safety of Echinaforce\u00ae in respiratory tract infections.",
    "Pagination": {
      "StartPage": "102",
      "EndPage": "105",
      "MedlinePgn": "102-5"
    },
    "Abstract": {
      "AbstractText": [
        "Echinaforce\u00ae is the standardised extract of Echinacea purpurea from Bioforce, Switzerland. Recent studies show immunomodulation and broad antiviral effects against respiratory tract viruses. Haemagglutinin and Neuraminidase are blocked. In contrast to Oseltamivir no resistance is caused by Echinaforce\u00ae. A randomised, double-blind, placebo-controlled study over four months confirms that Echinaforce\u00ae supports the immune resistance and acts directly against a series of viruses. Echinaforce\u00ae is efficacious and safe in respiratory tract infections for long-term and short-term prevention as well as for acute treatment."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Allergy Clinic, Hochwangstr. 3, 7302 Landquart, Switzerland. andreas@schapowal.ch"
          }
        ],
        "LastName": "Schapowal",
        "ForeName": "Andreas",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Austria",
    "MedlineTA": "Wien Med Wochenschr",
    "NlmUniqueID": "8708475",
    "ISSNLinking": "0043-5341"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Echinaforce"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunologic Factors"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Plant Extracts"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Double-Blind Method"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Echinacea"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Immunologic Factors"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Influenza, Human"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Phytotherapy"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Plant Extracts"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Randomized Controlled Trials as Topic"
    },
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "Respiratory Tract Infections"
    }
  ]
}